Most impactful areas to clinical real-world evidence as of 2018
This statistic depicts the percentage of executives that selected current and projected areas of most impact to real-world evidence (RWE) in clinical trials, as of 2018. According to the source, 60 percent of executives said that a better understanding of subpopulations and heterogeneity of treatment effects would be most impactful to current real-world evidence.
